Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2022 Sep 20;18(9):e1010400. doi: 10.1371/journal.pgen.1010400

Oocyte mitophagy is critical for extended reproductive longevity

Vanessa Cota 1, Salman Sohrabi 1,2, Rachel Kaletsky 1,2, Coleen T Murphy 1,2,*
Editor: Arjumand Ghazi3
PMCID: PMC9524673  PMID: 36126046

Abstract

Women’s reproductive cessation is the earliest sign of human aging and is caused by decreasing oocyte quality. Similarly, C. elegans’ reproduction declines in mid-adulthood and is caused by oocyte quality decline. Aberrant mitochondrial morphology is a hallmark of age-related dysfunction, but the role of mitochondrial morphology and dynamics in reproductive aging is unclear. We examined the requirements for mitochondrial fusion and fission in oocytes of both wild-type worms and the long-lived, long-reproducing insulin-like receptor mutant daf-2. We find that normal reproduction requires both fusion and fission, but that daf-2 mutants utilize a shift towards fission, but not fusion, to extend their reproductive span and oocyte health. daf-2 mutant oocytes’ mitochondria are punctate (fissioned) and this morphology is primed for mitophagy, as loss of the mitophagy regulator PINK-1 shortens daf-2’s reproductive span. daf-2 mutants maintain oocyte mitochondria quality with age at least in part through a shift toward punctate mitochondrial morphology and subsequent mitophagy. Supporting this model, Urolithin A, a metabolite that promotes mitophagy, extends reproductive span in wild-type mothers–even in mid-reproduction—by maintaining youthful oocytes with age. Our data suggest that promotion of mitophagy may be an effective strategy to maintain oocyte health with age.

Author summary

Female reproductive decline begins in a woman’s 30’s, and has become an increasingly important area of research as more women delay child bearing. Like women, the nematode C. elegans undergoes reproductive senescence starting in mid-life, and its reproductive span is determined by oocyte quality decline with age. One of the hallmarks of aging is an increase in mitochondrial dysfunction that can be driven by aberrant mitochondrial fission and fusion, the main regulators of metabolic function and mitochondrial dynamics. In this study we identified a mechanism that promotes reproductive longevity using mitochondrial fission and mitophagy, the trash compactor of dysfunctional mitochondria. This mechanism led us to test Urolithin A, a common metabolite that promotes mitophagy and extends lifespan in C. elegans, as a possible therapeutic to delay reproductive decline. We suggest promotion of mitophagy in oocytes as a new target to extend reproductive longevity through Urolithin A supplementation.

Introduction

Women’s reproductive aging is the first major age-related decline that humans experience [1], with increasing fertility issues, miscarriages, and aneuploid pregnancies that begin to arise in women in their mid-30s [2]. These reproductive aging issues have become increasingly important as the average maternal age rises [3,4]. The main contributor to reproductive decline is the age-associated decline of oocyte quality [5,6] rather than loss of oocytes [7]. The mitochondrion is a prime candidate for influencing reproductive aging: the mammalian oocyte contains the largest mtDNA copy number of any other cell [8,9], and mitochondrial dysfunction has been associated with reproductive aging and human oocyte quality decline [10,11].

Mitochondrial dynamics include fission and fusion, which may also play a role in reproductive health. The main drivers of mitochondrial fusion in mammals are Mfn1 and Mfn2 [12], and FZO-1 in yeast and invertebrates [12,13], while fission is controlled by the conserved dynamin-related protein DRP-1 [14,15]. Mouse oocytes with reduced levels of Mfn1 and Mfn2 show signs of mitochondrial and reproductive dysfunction [16,17]. Levels of Drp1 activity are reduced in aged oocytes, and Drp1 KO mice have reduced fertility due to fewer oocytes reaching maturity [18]. These data support a role for fission and fusion in reproduction, but many unanswered questions remain; specifically, how fission and fusion factors affect reproductive decline with age, and whether specific mitochondrial dynamics mechanisms play a role in reproductive longevity.

C. elegans is a useful model to study reproductive aging. As for women, C. elegans’ reproduction declines with age [19]. At the end of reproduction, C. elegans germ cells [20] and oocytes [21] deteriorate, fewer oocytes are fertilized, and fewer fertilized embryos hatch [21,22]. Therefore, as in humans, it is the decline of C. elegans oocyte quality, not the number of oocytes, that determines reproductive span. Furthermore, mutants that extend reproductive span have been identified, including the insulin/IGF-1 signaling (IIS) receptor mutant daf-2 [23]. While longevity and reproductive span extension can be uncoupled, such as in TGF-beta mutants [24], insulin/IGF-1 receptor mutants [25] are both long-lived and have a long reproductive span [23] due to the activation of the downstream FOXO transcription factor DAF-16 [24]. daf-2 mutants maintain germ cell integrity with age [20], maintain oocyte morphology with age, have fewer unfertilized oocytes, and produce more embryos that reach maturity [21,26]—all markers of high-quality oocytes.

Studies of mitochondria in mammalian and C. elegans somatic tissues have led to the prevailing model that the elongated morphology is associated with “youthfulness,” while punctate (“fragmented”) mitochondria are a sign of dysfunction, a hallmark of aging and age-related disease [27]. Mitochondria in C. elegans muscle cells [2832] and neurons [33,34] are elongated in youth and become punctate with age. daf-2 and mutants of the IIS pathway maintain the elongated mitochondria structure in body wall muscle and neurons longer than does wild type with age [28,30,31,33,34] (Fig 1L and 1M). These findings support a model in which mitochondrial elongation (fusion) is indicative of healthy, functional mitochondria in somatic tissue. However, whether similar mitochondrial dynamics are also required for oocyte health maintenance had not been explored.

Fig 1. daf-2 oocytes display punctate mitochondria.

Fig 1

daf-2 have an elongated reproductive span and maintain punctate morphology in oocyte mitochondria throughout reproduction. (A) daf-2(e1370) reproductive span in hermaphrodites (n = 96–121) mated with males (Luo et al. 2010). † indicates loss of hermaphrodites due to high rates of matricide by bagging. (B) daf-2(e1370) (n = 115) and N2 (n = 110) late-mating capability at Day 7 adult. Error bars represent 95% confidence interval. (C) Representative oocyte quality images. N2 (left panel) and daf-2(e1370) (right panel) at Day 1 and Day 8 adult. Black asterisks mark the -1 oocyte, white arrows highlight developing embryos, yellow dotted outline marks uterine mass. Scale bars represent 20μm. (D) Blind scoring of 4 categories of oocyte quality decline in daf-2(e1370) and N2 mated Day 8 hermaphrodites (n = 27–30). (E-F) Representative images of mitochondrial morphology using anti-ATP5α to mark mitochondrial membranes. Day 1 and Day 7 adults in N2 (E), and daf-2(e1370) (F). Scale bar 20μm. White-dotted boxes are enlarged sections of the -1 oocyte. Images were processed using the same parameters across the entire image (i.e. adjusting for brightness and contrast). (G-J) Quantification of mitochondrial morphology in the -1 oocyte. Z-stacks were blindly-scored into 3 categories: punctate, mixed, or elongated. Mitochondrial morphology does not change with age in N2 (G, n = 117–83) and daf-2(e1370) (H, n = 107–118). daf-2 have more -1 oocytes with punctate morphology at Day 1(I) and Day 7 (J). Three independent replicates were imaged, scored, and pooled for graphs G-J. Because blind scoring must be compared against the opposing genotype, G and H used the same blind scoring data as I and J. Chi-square test. (K) Mitochondrial length of N2 and daf-2 was measured using a subset of the same fixed samples used for blind scoring. Each dot represents the average length of 3 individual mitochondrion in one -1 oocyte. One-way Anova. (L) Muscle mitochondria of Day 7 adults using the ATP5a antibody. Images were taken on the confocal. Scale bar 5μm. (M) Muscle mitochondrial length was measured from the same samples used to characterize oocyte mitochondria. Each dot represents 1 of 10 mitochondrion in 6 individual worms for each genotype. Student t-test. ****p ≤ 0.0001.

Here we investigated the relationship between mitochondrial morphology, oocyte quality, and reproductive longevity. In contrast to the prevailing models of mitochondrial health, we find that the oocytes of the reproductive longevity mutant daf-2 maintain punctate mitochondrial morphology throughout their extended reproduction–even while their skeletal muscle mitochondria are elongated—while wild-type oocyte mitochondria maintain their elongated morphology with age, even while losing reproductive capacity. Therefore, elongated mitochondrial morphology is uncoupled from youthful function in both daf-2 and wild-type oocytes. We also find that wild-type oocytes require both fission and fusion for reproductive health, but daf-2 employs a strategy of fission and subsequent PINK-1-mediated mitophagy to maintain oocyte quality and reproductive longevity. Importantly, we show here that promoting mitophagy through Urolithin A treatment slows reproductive decline in wild-type animals, suggesting that daf-2’s shift toward fission and mitophagy can be applied to wild-type oocyte mitochondria to improve their oocyte health. Taken together, our data support an alternative strategy for oocyte quality maintenance that engages mitochondrial dynamics and elimination to promote reproductive longevity.

Results

daf-2 oocyte mitochondria are punctate

The insulin-like receptor mutant daf-2 has an extended lifespan [25], an extended self-fertilized reproductive span [23], and an extended mated reproductive span [24] (Fig 1A). In mated reproductive span assays, hermaphrodites are mated with young wild-type males for 24 hr to avoid convolution with sperm-dependent effects, such as age-impairment of sperm or depletion of self-sperm [22,24] that arise in self-mated (unmated) assays; thus, mated reproductive spans specifically reflect competency of aged oocytes rather than sperm. In a similar test of age-associated reproductive decline, aged daf-2(e1370) and wild type (N2) were mated with young males on Day 7 of adulthood (“late mating”) to ask whether older animals, at the end of the reproductive span, are reproductively capable and still able to produce progeny. In agreement with the mated reproductive spans, significantly more old (Day 7) daf-2 worms are able to produce progeny with age (Fig 1B). daf-2 extends reproductive span by maintaining oocyte quality with age [21,26]. By Day 8 of adulthood, daf-2(e1370) mutants still maintain large, uniform, cuboidal oocytes [21], while wild-type oocytes deteriorate [21] (Fig 1C and 1D).

To determine how mitochondria impact oocyte quality and reproductive longevity, we first examined mitochondrial morphology. daf-2 prevents mitochondrial fragmentation during aging in muscle cells [30,31,35] and neurons [33,34], therefore, we hypothesized that daf-2 may similarly prevent oocyte mitochondrial fragmentation and maintain elongated mitochondria with age. To test this hypothesis, we examined the mitochondrial morphology of the most mature oocyte, the -1 oocyte, in Day 1 and Day 7 wild-type and daf-2(e1370) adults using the mitochondrial membrane marker ATP5α, which circumvents potential effects on mitochondrial morphology from GFP fusion proteins [36]. Oocytes were imaged and blindly scored for three categories characterizing morphology: elongated (majority of mitochondria in the oocyte are tubular and networked), punctate (majority of mitochondria in the oocyte are small, mainly round, and not interconnected), and mixed (both punctate and elongated forms are represented in the mitochondria population). First, we found that the majority of wild-type oocyte mitochondria appear elongated and tubular in young Day 1 adults, consistent with a previous report [37]. However, this morphology distribution does not change significantly with age or reproductive ability (Figs 1E, 1G, S1A and S1B, S1S3 Videos). This result suggests that the elongated state of mitochondria in wild-type oocytes does not correlate with “health,” as this morphology persists even as the oocytes lose function.

Because high-quality mitochondria are often described as “elongated” while low-quality mitochondria are often described as “fragmented,“and daf-2 skeletal mitochondria are reported to be elongated [30,31] we were also surprised to find that the mitochondria in daf-2–1 oocytes are not primarily elongated and tubular; instead, daf-2 oocyte mitochondria appear largely punctate in both young (Day 1) and old (Day 7) animals (Figs 1F, 1H and S1A and S1B, S4S6 Videos), suggesting that rather than fragmenting from an originally elongated state, daf-2 oocyte mitochondria maintain a punctate state throughout reproduction. Furthermore, daf-2 mutants have significantly more -1 oocytes displaying a punctate morphology than does wild type at either Day 1 or Day 7 (Fig 1I and 1J). To complement the blind scoring results, we measured mitochondrial length; mitochondrial length does not change with age in either N2 or daf-2 oocytes, but daf-2’s oocyte mitochondria are significantly shorter than wild-type’s mitochondria on both Day 1 and Day 7 (Fig 1K).

To confirm that skeletal muscle mitochondria morphology was consistent with previously published results [30,31] using the ATP5α antibody, we measured muscle mitochondrial length in the same samples that we used to collect oocyte images. Aged daf-2(e1370) muscle mitochondria are significantly longer than aged wild-type muscle mitochondria (Figs 1L and 1M and S1C), as previously reported [30,31]. That is, the mitochondria in oocytes and skeletal muscle of the same animals show distinct morphologies, despite the fact that both muscle and oocytes of daf-2 animals exhibit extended functional abilities [38]. The punctate morphology maintained with age in daf-2 oocytes suggests that an alternative mechanism may be employed by oocyte mitochondria to combat age-related reproductive decline, distinct from daf-2’s maintenance of elongated mitochondria in aged somatic tissues.

Fission and fusion maintain reproduction with age

The punctate morphology of daf-2 oocyte mitochondria is distinct from their morphology in somatic tissues as well as from the morphology of wild-type oocyte mitochondria, which suggests mitochondrial dynamics are differentially regulated in daf-2 reproduction. Therefore, we investigated the roles of regulators of mitochondrial dynamics in reproduction, DRP-1 (Dynamin-Related Protein 1) and FZO-1 (mitofusin 1/2). C. elegans mutants that lack fission (drp-1(tm1108)) or fusion (fzo-1(tm1133)) do not exhibit differences in lifespan [32,39] (S2A and S2B Fig), but whether fission and fusion regulate reproductive aging is unknown. The -1 oocyte mitochondria of drp-1 mutants are elongated, while fzo-1 oocyte mitochondria are punctate (Fig 2A–2C), as expected. The mated reproductive spans of both drp-1(tm1108) (Fig 2D) and fzo-1(tm1133) (Fig 2E) are significantly shorter than wild type’s reproductive span. Knockdown of either drp-1 or fzo-1 by RNAi results in a decrease in brood size [40], though whether this progeny loss is due to dysfunctional sperm is unknown. Therefore, we assayed the fission and fusion mutants that were mated with wild-type sperm and found on all the days tested the brood sizes of drp-1(tm1108) and fzo-1(tm1133) are reduced (S2C Fig). In another sign of oocyte quality decline, both the fission and fusion mutants lay significantly more unhatched embryos (Fig 2F). Taken together, these data suggest that disruption in either fission or fusion results in defective oocytes, impairing reproduction.

Fig 2. Fission and fusion are necessary for normal reproductive function with age.

Fig 2

(A) Mitochondrial morphology in mature oocytes of N2, drp-1(tm1108), and fzo-1(tm1133) in Day 3 adults. Representative images highlight the different morphologies in N2 (elongated), drp-1(tm1108) (elongated), and fzo-1(tm1133) (punctate). White-dotted boxes are enlarged (right) of the morphology in the -1 oocyte (I) and the -2 oocyte (II). Images in A were processed using the same parameters across the entire image (i.e. adjusting for brightness and contrast). (B) Blind scoring results of mitochondrial morphology in the -1 oocyte in Day 3 adults of N2 (n = 34), drp-1(tm1108) (n = 29), and fzo-1(tm1133) (n = 29). (C) Mitochondrial length measurements. Each dot represents 1 of 3 measurements from the -1 oocyte of 20–25 individual hermaphrodites in each genotype. Reproductive spans of mated drp-1(tm1108) (D, n = 96–109) and fzo-1(tm1133) (E, n = 70–89). (F) Embryonic lethality in N2, drp-1, and fzo-1. Representative data from days 3, 4, and 5 of adulthood are shown due to high rates of matricide after day 5 (n = 11–13). 2-way Anova. (G-H) Oocyte quality declines with age in drp-1(tm1108). Representative oocyte quality images in Day 1 (G) and Day 6 (H) adults of N2 (left panel) and drp-1(tm1108) (right panel). Highlighted features include: embryos in the uterus (white arrows), the -1 oocyte (black asterisk), oocyte quality-decline phenotypes (yellow text and arrows), uterine mass (yellow dotted outline). (I) Quantification of oocyte quality decline phenotypes in N2 (n = 64) and drp-1(tm1108) (n = 51). (J-K) Oocyte quality declines in fzo-1(tm1133). Representative oocyte quality images in Day 1 (J) and Day 6 (K) adults of N2 (left panel) and fzo-1(tm1133) (right panel). Highlighted features same as H. Scale bars 20μm. (L) Quantification of oocyte quality decline phenotypes in N2 (n = 38) and fzo-1(tm1133) (n = 34). Chi-square test. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.

To determine how loss of mitochondrial fission or fusion affects oocyte quality, we imaged age-matched hermaphrodite germlines and assessed oocyte quality phenotypes. On Day 6 of adulthood, which is near the end of wild type’s reproductive span, there is a significantly higher incidence of misshapen and smaller oocytes in drp-1(tm1108) fission mutants compared to N2, and many had a mass of oocytes or other cellular material in the uterus (“uterine mass”) rather than normally developing embryos (Fig 2H and 2I). Moreover, the oocyte quality phenotypes observed in aged drp-1(tm1108) are not present in young adults (Fig 2G) suggesting this decline is dependent on age. Aged fzo-1 fusion mutant oocytes display severe or mild uterine masses in place of developing embryos in the majority of the population (Fig 2K and 2L). Again, this uterine mass does not appear in young adults (Day 1, Fig 2J). These results suggest that the primary regulators of both fission and fusion are required for normal reproductive health through the maintenance of oocyte quality with age.

Reproductive longevity requires fission

We next asked whether the punctate state of daf-2 oocyte mitochondria is necessary for daf-2’s extended reproductive span; if daf-2 specifically requires the punctate morphology in oocytes, then eliminating fission through loss of drp-1 should prevent daf-2’s maintenance of reproduction. We first confirmed that the mitochondria in the -1 oocyte of daf-2(e1370);drp-1(tm1108) mutants are elongated, not punctate (Fig 3A–3C). The mated reproductive span and the related late-mating reproductive capability are both significantly reduced in daf-2(e1370);drp-1(tm1108) (Fig 3D and 3F), suggesting that the punctate state is required for daf-2 reproductive span extension. By contrast, knocking out the fusion protein FZO-1, thereby promoting fission resulting in primarily punctate mitochondria like daf-2 (Fig 3A–3C) does not affect reproduction: loss of FZO-1 does not change daf-2’s extended reproductive span (Fig 3E) and does not affect daf-2’s reproductive capability in aged hermaphrodites (Fig 3F). Therefore, daf-2 requires mitochondrial fission, but not fusion, to preserve reproductive function with age.

Fig 3. daf-2 requires fission, not fusion, for reproductive longevity.

Fig 3

(A) Representative images of Day 4 adult mitochondrial morphology in the -1 oocyte marked with anti-ATP5α. White-dotted boxes are enlarged (right) of the morphology in the -1 oocyte (I and II). Scale bar 10μm. Images in A were processed using the same parameters across the entire image (i.e. adjusting for brightness and contrast). (B) Blind scoring results of mitochondrial morphology of the -1 oocyte in three categories: punctate, mixed, or elongated of daf-2(e1370) (n = 30), daf-2(e1370);drp-1(tm1108) (n = 46), and daf-2(e1370);fzo-1(tm1133) (n = 56). (C) Mitochondrial length measurements. Each dot is 1 of 3 measurements from the -1 oocyte from 20–25 individual hermaphrodites in each genotype. (D) Fission knockout daf-2(e1370);drp-1(tm1108) (n = 96) has a reduced reproductive span compared to daf-2(e1370) (n = 121) in mated hermaphrodites. (E) Fusion knockout daf-2(e1370);fzo-1(tm1133) (n = 101) maintain an elongated reproductive span compared to daf-2(e1370) (n = 102). In D and E † indicates loss of hermaphrodites due to high rates of matricide. (F) Late-mating of daf-2(e1370) (n = 103), daf-2(e1370);drp-1(tm1108) (n = 79), and daf-2(e1370);fzo-1(tm1133) (n = 102). Error bars represent 95% confidence interval. (G) Representative images of oocyte quality in daf-2(e1370) (left panel) and daf-2;drp-1 (right panel) in Day 8 adults. Highlighted features include: embryos in the uterus (white arrows), the -1 oocyte (black asterisk), uterine mass (yellow dotted outline). Scale bar is 20μm. (H) Quantification of oocyte quality phenotypes from daf-2(e1370) (n = 41) and daf-2(e1370);drp-1(tm1108) (n = 39) in Day 8 adults. (I) Oocyte quality does not decline with age in daf-2;fzo-1. Quantification of oocyte quality features in daf-2 (19–21) and daf-2;fzo-1 (30–33). (J) Embryonic lethality in daf-2(e1370);drp-1(tm1108) and daf-2(e1370). Representative data from days 3, 4, and 5 of adulthood are shown due to high rates of matricide after day 5 (n = 11–13). (K) Lifespans of daf-2(e1370);drp-1(tm1108) (n = 81) and daf-2(e1370) (n = 80) or (L) daf-2(e1370);fzo-1(tm1133) (n = 80) and daf-2(e1370) (n = 81) are unchanged. **p ≤ 0.01, ****p ≤ 0.0001.

We next asked whether the requirement for DRP-1 in daf-2’s extended reproductive longevity is through the maintenance of oocyte quality. While the “uterine mass” phenotype is not present in younger adults (Day 5, S3A Fig), by Day 8 the majority of mated daf-2(e1370);drp-1(tm1108) mutants have developed large masses (instead of developing embryos) in their uteri (Fig 3G and 3H), confirming it as a reproductive aging phenotype. Loss of fusion (daf-2;fzo-1) has no effect on daf-2 oocyte quality (Figs 3I and S3B). Consistent with a decrease in oocyte quality, daf-2(e1370);drp-1(tm1108) mutants lay a high percentage of unhatched embryos on days 3, 4, and 5 of adulthood (Fig 3J). Together, our data suggest that retaining the punctate state of mitochondria through fission is required for daf-2’s maintenance of high-quality oocytes with age, which in turn is critical for its extended reproductive span.

Despite the dramatic effect on daf-2 oocyte quality and reproductive span, neither loss of DRP-1 or FZO-1 affected the extended lifespan of daf-2 mutants (Fig 3K and 3L), suggesting that mitochondrial dynamics specifically affect reproductive longevity through oocyte quality maintenance with age.

daf-2’s extended reproductive longevity requires mitophagy

Mitochondria that have accumulated damage divide asymmetrically through fission [41] and activate mitophagy to eliminate mitochondria that are beyond repair [41]. One possible benefit to daf-2 maintaining punctate mitochondria in oocytes is they may be primed for mitophagy, which provides quality control for damaged mitochondria. For example, study of induced mitochondrial DNA damage in Drosophila early oogenesis revealed that mitochondria undergo fragmentation to selectively remove mitochondria with mutated mtDNA through mitophagy [42], and mid-life induction of Drp1-mediated skeletal muscle mitochondrial fission and lifespan extension in Drosophila require autophagy/mitophagy [43]. We used the SKI LODGE system [44] to generate a mitophagy reporter (mtRosella) [29,45,46], confirmed it was correctly inserted behind the germline-specific pie-1 promoter, but found that it is silenced in the germline (S4A Fig). Therefore, we instead used a genetic approach to ask whether mitophagy is required for daf-2’s extended reproductive span. The main mitophagy pathway activator in C. elegans is PINK-1 (PTEN induced kinase 1), which is conserved in yeast, flies, worms, and humans, and functions by accumulating on dysfunctional mitochondria [4749]. We found that aged daf-2(e1370);pink-1(tm1779) double mutants have reduced reproductive capability after late (Day 7) mating (Fig 4A). (daf-2;pink-1 mutants exhibit high rates of matricide, preventing the analysis of full reproductive spans; however, both mutants have similar mating ability (S4B Fig), suggesting the reduction in reproductive ability is an aging phenotype.) Further, similar to daf-2(e1370);drp-1(tm1108) mutants, mated Day 8 daf-2;pink-1 hermaphrodites exhibited a significant number of uterine masses rather than developing embryos (Fig 4B and 4C; compare to 3G and 3H), suggesting that the uterine mass phenotype is a result of mitochondrial dysfunction in aging oocytes brought on by the loss of mitophagy. There is no difference between the reproductive spans of N2 and pink-1(tm1133) (Fig 4D) or late-mating capability (S4C Fig), suggesting that PINK-1 may be specifically required for reproductive longevity mechanisms that favor the elimination of damaged, fissioned mitochondria. Further, like fission and fusion regulators, PINK-1 is not required for somatic longevity in daf-2 (Fig 4E) or wild type (S4D Fig). Taken together, our results support a model in which punctate mitochondria are primed for mitophagy specifically in daf-2 oocytes to promote reproductive longevity.

Fig 4. Mitophagy is required for daf-2’s extended reproductive capability.

Fig 4

(A) Late-mating of daf-2(e1370) (n = 70) and daf-2(e1370);pink-1(tm1779) (n = 66). Late-mating performed on age-matched Day 7 hermaphrodites provided with young males. Error bars represent 95% confidence interval. (B) Representative images of oocyte quality assay of daf-2(e1370);pink-1(tm1779) in aged adult germlines (Day 8). Highlighted features include: embryos in the uterus (white arrows), the -1 oocyte (black asterisk), uterine mass (yellow dotted outline). Scale bar is 20μm. (C) Quantification of oocyte quality phenotypes in daf-2(e1370) (n = 45) and daf-2(e1370);drp-1(tm1108) (n = 51). (D) There is no significant difference between the mated reproductive spans of N2 (n = 59) and pink-1(tm1779) (n = 63). (E) No change between the lifespan of daf-2(e1370);pink-1(tm1779) compared to daf-2(e1370) alone (n = 66–79). + indicates censorship due to covid-19 shutdown. **p ≤ 0.01, ****p ≤ 0.0001.

Urolithin A slows reproductive decline

Given that daf-2’s reproductive span is double that of wild type’s and that daf-2 requires mitophagy, we asked whether wild-type animals’ reproduction could be improved by promoting mitophagy. Urolithin A (UA) is an ellagitannin metabolite [50,51] that increases mitophagy through the accumulation and stabilization of PINK-1 [46,52]. UA increases lifespan in worms [52] through the upregulation of mitophagy [46,52,53], improves muscle function in aged mice [52], and increases mitophagy in muscular dystrophy mouse models and human patients [53,54]. Besides muscle function, Urolithin A has been found to improve the function of a variety of tissues and organs through mitophagy upregulation [55]; however, whether UA supplementation affects age-related reproductive decline is unknown. Therefore, we asked whether Urolithin A (UA) supplementation would increase the reproductive span in wild-type C. elegans.

Supplementing mated wild-type hermaphrodites with UA at the start of reproduction (Day 1) significantly extended reproductive span (Fig 5A; 14% increase, p<0.0001). Furthermore, when worms are supplemented with UA at the start of reproductive decline (Day 4), late-start UA treatment still significantly extended the reproductive span of wild-type animals (Fig 5B), suggesting UA treatment acts quickly to improve oocytes even when given in middle-aged adults. Treatment of mated pink-1(tm1779) mutants with UA did not increase reproductive span (Fig 5C), suggesting that UA-mediated reproductive span extension requires PINK-1-mediated mitophagy.

Fig 5. Urolithin A treatment slows reproductive decline in wild type.

Fig 5

(A) Reproductive span of N2 control 0.3% DMSO (n = 100) and N2 50μM UA, 0.3% DMSO (n = 100). Treatment started on Day 1 of adulthood. (B) Reproductive span of N2 hermaphrodites with Urolithin A treatment starting at Day 4 of adulthood is improved. Both control (n = 100) and experimental (n = 100) groups began 0.3% DMSO at Day 1 and UA treatment began at Day 4 in the experimental group. p = 0.0062 (C) Reproductive span of pink-1(tm1779) is unchanged with UA treatment. Control 0.3% DMSO (n = 100) and experimental 50μM UA, 0.3% DMSO (n = 100). In A and C mated hermaphrodites were loaded into Celab and started treatment on Day 1. (D) Representative images of oocyte quality in control (left panel) and UA treated (right panel) N2 worms at Day 6. Highlighted features include: embryos in the uterus (white arrows), the -1 oocyte (white asterisk), and oocyte quality decline phenotypes (yellow text). (E) Quantification of oocyte quality phenotypes at Day 6 of adulthood in control (n = 53–55) and UA treated groups (n = 48–50). (F) Representative images of oocyte quality in control (left panel) and UA treated (right panel) fzo-1(tm133) worms at Day 6. Highlighted features include: embryos in the uterus (white arrows), the -1 oocyte (black asterisk), and oocyte quality decline phenotypes (yellow text). (G) Quantification of oocyte quality phenotypes at Day 6 of adulthood in fzo-1 control (n = 38–43) and fzo-1 UA treated groups (n = 37–41). (H) Representative images of oocyte quality in control (left panel) and UA treated (right panel) drp-1(tm1108) worms at Day 6. (I) Quantification of oocyte quality phenotypes at Day 6 of adulthood in drp-1 control (n = 52) and drp-1 UA treated groups (n = 50). (J) Wild type requires both fission and fusion, but not mitophagy, to maintain a normal reproductive span. Reproductive longevity in daf-2 requires fissioned mitochondria, which are then primed for and utilize mitophagy to maintain reproductive longevity through oocyte quality maintenance. (K) Urolithin A, a mitophagy promoter, extends reproductive span in wild type with adult only treatment at Day 1 or Day 4 of adulthood. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.

Day 6 adult-only UA-treated worms had significantly more large and uniformly shaped oocytes, which are signs of youthfulness (Fig 5D and 5E). Further, in fzo-1 mutants, in which the majority of mitochondria are punctate due to loss of fusion (Fig 2A–2C), oocyte quality is improved with UA treatment and the uterine mass phenotype seen in fzo-1 mutants alone (Fig 2J and 2K) is partially corrected (Fig 5F and 5G). By contrast, Urolithin A treatment of drp-1 did not significantly improve oocyte quality decline phenotypes (Fig 5H and 5I). Therefore, while we cannot solely attribute the positive effects of UA treatment to its function in oocytes, as drug treatment is administered to the whole animal and therefore might affect non-oocyte tissues, we can conclude that adult treatment with Urolithin A can improve oocyte quality maintenance with age and subsequently extend the reproductive span of wild-type animals. Urolithin A might function by shifting the mitochondrial maintenance strategy to mitophagy, as daf-2 mutants do through PINK-1 function.

Here we have uncovered a mitochondrial mitophagy-based mechanism to promote reproductive longevity. We found that daf-2’s reproductive span extension and oocyte quality maintenance require mitochondrial fission (DRP-1) and mitophagy (PINK-1) (Fig 5J). Further, our data suggest that mitophagy is a main player in oocyte quality maintenance and reproductive span extension. In support of this conclusion, Urolithin A, a metabolite that promotes mitophagy through PINK-1, improves the reproductive span in wild-type worms by maintaining oocyte quality (Fig 5K).

Discussion

We sought to determine whether mitochondrial morphology influences oocyte quality and reproductive span, and whether there is an ideal morphology that promotes reproductive health. daf-2 appears to use a strategy of promoting fission and subsequent mitophagy to increase reproductive longevity, requiring DRP-1 to tip the balance of mitochondria to the fissioned, punctate state. This result was surprising, as punctate mitochondria are usually thought to be dysfunctional, and are often referred to as “fragmented.” However, in the case of daf-2’s reproduction, punctate mitochondria are beneficial. This benefit may be due to the fact that fissioned mitochondria activate the mitophagy pathway [56]; indeed, we find that mitophagy is required for daf-2’s extended reproductive span. In this model, dysfunctional mitochondria may be removed from the mitochondria pool through PINK-1-mediated mitophagy, and this mechanism assists in slowing oocyte quality decline, thereby extending reproduction (Fig 5J). Moreover, applying this strategy to wild-type oocyte mitochondria through the use of Urolithin A improves oocyte quality with age and extends reproductive span.

Insulin/IGF-1 receptor mutants retain elongated mitochondria in muscle and neurons later in life [28,30,33,34], which supports the model that fusion promotes longevity. However, promoting fusion, either by knocking out the fission protein DRP-1 or by overexpressing the fusion protein FZO-1, has no effect on lifespan [32] (S2A and S2B Fig). These data suggest that neither fusion nor fission is the main driver of somatic lifespan. Instead, we have shown here that mitochondrial morphology and dynamics specifically regulate C. elegans reproductive span. In fact, most mitochondria (95%) [57] in the C. elegans adult is present in the germline, not somatic tissues, and oocyte production results in up to a 6-fold increase in the mtDNA copy number [58]. The tissue-specific effect that mitochondrial dynamics has on reproduction is mirrored in daf-2 mutants: the loss of drp-1 and fzo-1 from daf-2(e1370) has no effect on lifespan (Fig 3K and 3L). PINK-1-mediated mitophagy also appears to play no role in daf-2 somatic longevity (Fig 4E), although autophagic activity [29,59], mitophagy, and mitochondrial biogenesis mechanisms are upregulated in daf-2 mutants [29]. These results suggest that somatic lifespan and reproductive span have distinct requirements for mitochondrial morphology and employ different, tissue-specific mechanisms to combat age-related mitochondrial dysfunction. These distinct mechanisms may also be regulated differently, as our expression analysis [26] suggests these proteins are not regulated transcriptionally in oocytes. Together, our data suggest that the requirement of mitochondrial dynamics specifically for reproduction, rather than somatic longevity, reflects the need for high-quality oocytes for successful progeny development. Contrary to the view that tubular, elongated mitochondria are healthier than fissioned, punctate mitochondria, the pro-fission and PINK-1-mediated mitophagy mechanism used by daf-2 mutants to maintain oocyte quality with age is an alternative strategy to promote reproductive longevity.

By using daf-2 as a model, we have found that promoting mitophagy in wild-type oocytes can help improve oocyte quality and slow reproductive decline (Fig 5A and 5B, 5D and 5E). Extending wild type’s reproductive span through oocyte quality maintenance with Urolithin A supplementation supports the model that enhanced mitophagy at least in part promotes reproductive span extension. Our data show that not all mitochondria in wild-type oocytes are elongated, and some punctate mitochondria are present in mature oocytes. Therefore, promoting the stabilization of PINK-1 would allow the activation of mitophagy on punctate/fissioned mitochondria in wild-type oocytes. In further support of this model, when oocyte mitochondria are primarily in the punctate state, as in the fission mutant fzo-1, we see an improvement of oocyte morphology with age (Fig 5F and 5G).

Mechanisms to slow reproductive decline have become increasingly important as the average maternal age increases [16]. The role of mitophagy in daf-2’s extended reproductive span provides an alternative strategy to combat age-related reproductive decline and supports investigating mitophagy as a means to promote reproductive health with age. Urolithin A (UA) was recently identified to improve lifespan and healthspan by combating mitochondrial dysfunction and age-related decline via upregulation of mitophagy [52]. Further, Urolithin A has been found to be safe and effective in humans and improves muscle strength [53,60]. A recent ‘in vitro aging’ study of bovine oocytes suggests that UA may be beneficial for mammalian in vitro ART applications [61]. Our in vivo studies of reproductive aging suggest that UA may improve reproductive span with age by promoting maintenance of oocyte quality, supporting our model that mitophagy may be a key component to combating reproductive decline. Further, we show improvement to reproduction can begin with UA treatment in both early and mid-reproductive adulthood (Day 4 in worms, which is equivalent to approximately 35 years in women). UA supplementation has been found to have a positive effect on a variety of tissues and age-related decline phenotypes [55]. Our data suggest that UA may also have potential therapeutic benefits to reproductive health in other organisms.

Experimental model and subject details

C. elegans strains

The following strains were used in this study: N2 Bristol strain as wild type worms, CB4108:

fog-2(q71) V males for mating experiments, CB1370: daf-2(e1370), CU6372: drp-1(tm1108), CU5991: fzo-1(tm1133), pink-1(tm1779). The following crosses were performed: CQ613:

daf-2(e1370);drp-1(tm1108), CQ611: daf-2(e1370);fzo-1(tm1133), and CQ659: daf-2(e1370);pink-1(tm1779).

Method details

General worm maintenance

All strains were cultured using standard methods [62]. For all experiments, worms were maintained at 20°C. Nematode growth medium (NGM: 3 g/L NaCl, 2.5 g/L Bacto- peptone, 17 g/L Bacto-agar in distilled water, with 1mL/L cholesterol (5 mg/mL in ethanol), 1 mL/L 1M CaCl2, 1 mL/L 1M MgSO4, and 25 mL/L 1M potassium phosphate buffer (pH 6.0) was added to molten agar after autoclaving. Plates were seeded with OP50 E. coli for ad libitum feeding. To synchronize experimental groups, gravid hermaphrodites were used to collect eggs by treating them with a 15% hypochlorite solution (e.g., 8.0 mL water, 0.5 mL 5N KOH, 1.5 mL sodium hypochlorite) and vortexing, followed by repeated washing of collected eggs in M9 buffer [62].

Germline mtRosella strain

The TOMM-20::mtRosella insert was isolated from the Pmyo-3TOMM-20::mtRosella (IR1631) strain [29]. We then used the SKI LODGE [44] co-CRISPR strategy, which uses a single-copy tissue specific promoter for transgenic cassette insertions. Using the germline-specific pie-1 promoter strain (WMB1119), we injected the co-CRISPR mix and confirmed the Ppie-1TOMM-20::mtRosella via sequencing. Next, we dissected and imaged germlines using the Nikon eclipse Ti at 60x magnification and took Z-stack images in 0.7 μm steps. The images shown in the supplement are superimposed Z-stacks of each fluorescent channel.

Reproductive span and lifespan assays

Mated reproductive spans were performed as previously described [24]. Eggs were synchronized with a hypochlorite solution and selected for experiments at the L4 stage. Hermaphrodites were mated with fog-2(q71) males at a 2:1 ratio for 24 hrs from L4 to Day 1 of adulthood, then were removed from males to prevent further mating. Each hermaphrodite was singled onto a 35mm NGM plate and moved to new plates every 24 hours until the end of the reproductive span. 48 hours after removal, plates were screened for progeny to confirm reproductive span, including male progeny to confirm a successful mating. Reproductive cessation was defined as the last day of progeny production preceding two full days without progeny. If bagging was observed, hermaphrodites were censored on the day of matricide (defined as progeny hatched within mother). All reproductive spans were performed at 20°C.

Lifespan assays were performed as previously described [25]. In brief, groups of hypochlorite-synchronized hermaphrodites (<15 per plate) were placed on plates at the L4 stage. The hermaphrodites were transferred to freshly seeded plates every two days when producing progeny, and 2–3 days thereafter. Worms were censored on the day of matricide (defined as progeny hatching within mother), abnormal vulva structures, or loss. Worms were defined as dead when they no longer responded to touch. All lifespans were performed at 20°C.

Oocyte quality assays

Assays were performed as previously described [21,26]. Hypochlorite-synchronized hermaphrodites were mated for 24 hrs on either L4 or Day 1 of adulthood. Mating was confirmed as in the reproductive span by confirming the presence of male progeny. Groups of hermaphrodites were maintained until the day of the experiment (Day 6-Day 8 of adulthood); hermaphrodites were added to slides with 3–4% agarose pads in M9 with levamisole. DIC images were captured on a Nikon eclipse Ti at 60x magnification. The scorer was blinded to genotype and each image was given a score (normal, mild, severe) in each oocyte quality category. Note that in experiments using daf-2(e1370) background, worms were added to plates with serotonin for 1 hour on Day 6 and Day 8 to purge embryos and prevent matricide.

Late-mating assay

Late-mating assays were performed as previously described [63]. Hypochlorite-synchronized worms were selected at the L4 stage. Hermaphrodites were aged to Day 7, moving every two days to separate from progeny. On the day of late mating, hermaphrodites were individually placed onto 35mm plates seeded with 25uL spots of OP50. fog-2(q71) males were added at a 3:1 ratio and the presence of progeny was scored 4–5 days after males were added to the plates.

Embryonic lethality assay and progeny counts

Assay was performed as described [21]. L4 hermaphrodites were singled onto 35mm NGM plates and males were added at a 3:1 ratio for mating. Mating was confirmed as in the reproductive span, and mated hermaphrodites were removed from males by transfer to a new plate. Every 24 hours, hermaphrodites were moved to new plates. Approximately 24 hours after removal, plates were scored for numbers of progeny, unhatched embryos, and unfertilized oocytes. Counting continued throughout reproductive span until the hermaphrodites’ numbers fell below 10. Percent unhatched is the proportion of embryos that failed to hatch after 24 hours.

Mitochondria morphology

Mitochondria morphology was assessed using immunohistochemistry staining with the mitochondria membrane marker ATP5α. Germline immunostaining was performed using the protocol as in [64]. In brief, hypochlorite-synchronized hermaphrodites were maintained until the day of interest. Hermaphrodite germlines were dissected and fixed using a methanol/acetone fixation. Primary antibody was from AbCam Mouse Anti- ATP5α antibody [15H4C4], and secondary was Invitrogen Goat Polyclonal Secondary Antibody Alexa Fluor Plus 555. Imaging was performed on point scanning confocal Nikon A1 at either 100x or 60x or Nikon eclipse Ti. Images were taken on a Z-stack (0.7–1.0 μm steps) focusing on the -1 oocyte. For mitochondria morphology quantification, images from 2–4 genotypes were collected and file names were blinded. Each Z-stack was then assessed for a morphology qualification (punctate, mixed, elongated). Images were processed in FIJI and Adobe Photoshop. Each figure of images shown were from the same experiment, imaged on the same microscope at the same magnification, and with the same exposure. All images in each figure were processed in the same way across the entire image (e.g., adjusting for brightness and contrast).

Urolithin A treatment reproductive and lifespans

Urolithin A was obtained through Fisher Scientific and diluted in DMSO. The control is composed of the incubation solution with 0.3% v/v DMSO, and the experimental incubation solution has 0.3% v/v DMSO and 50 μM Urolithin A. Urolithin A supplementation was administered using CeLab, a miniature C. elegans Lab-on-chip device designed to carry out a variety of worm assays such as lifespan, reproductive span, and brood size assays at high throughput. This multi-layered microfluidic device is fabricated using standard soft lithography. 200 worms are loaded into separate incubation arenas of each chip. After mating L4 animals on NGM plates for 24 hours, mated Day 1 worms are loaded into CeLab and are incubated in S-medium with 60 OD600 OP50-1, 50 mg/l streptomycin, and 10 mg/l nystatin. Each animal’s reproductive span and lifespan are daily scored using CeAid, a smartphone application for logging worm assays [65]. After scoring each day, progeny are flushed out of the chip using M9 buffer solution for 20 min and then the incubation solution is replenished.

Urolithin A treatment oocyte quality assays

L4 worms were mated on NGM plates seeded with OP50 for 24 hours. On Day 1 of adulthood hermaphrodites were separated from males and transferred to NGM plates that were prepared with either 0.3% v/v DMSO or 0.3% v/v DMSO and either 50 μM (or 100 μM) Urolithin A. Hermaphrodites were moved to fresh DMSO control or DMSO plus Urolithin A plates every 2 days until Day 6 of adulthood. Oocyte quality imaging was performed as described above on Day 6 of adulthood.

Quantification and statistical analysis

Lifespans and reproductive span assays were assessed using the standard Kaplan-Meier log rank survival tests. The first day of adulthood was defined as t = 0. Oocyte quality assays used a chi square test to determine whether there was any significant difference between populations for each oocyte quality category. Embryonic lethality assays used a two-way Anova to compare across experimental days and genotypes. In late-mating assays chi-square tests were used to compare percentages of reproductive and non-reproductive populations across genotypes. Error bars represent 95% confidence interval. For morphology analysis, chi-square tests were used to compare the percentages of the population within each morphology category.

All experiments were repeated on separate days with separate, independent populations. Details of each represented experiment, including sample sizes, can be found in the figure legend. All figures in the Article and Supplement shown are of 1/3 (or in some cases 1/2) biological replicates, with the exception of the mitochondrial morphology scoring, which are pooled data from 3 independent experiments. Prism 9 software was used for statistical analysis.

Supporting information

S1 Fig. Mitochondrial morphology in N2 and daf-2 oocytes and muscle.

(A) Day 1 adult mitochondrial morphology images in the -1 oocytes of N2 (left 2 panels) and daf-2(e1370) (right 2 panels). (B) Day 7 adult mitochondrial morphology images in the -1 oocytes of N2 (left 2 panels) and daf-2(e1370) (right 2 panels). In A and B images were taken on the Nikon eclipse Ti at 60x magnification. (C) Day 7 adult mitochondrial morphology images in the muscle of N2 (left 2 panels) and daf-2(e1370) (right 2 panels). In C images were taken on the scanning confocal Nikon A1 at 60x. All images are of mitochondria stained with ATP5α to mark membranes.

(PDF)

S2 Fig. Mitochondrial dynamics are specifically required for reproduction function.

(A) Lifespans are not affected by loss of drp-1(tm1108) (n = 81, N2 n = 81) (B) fzo-1(tm1133) (n = 80, N2 n = 83). (C) Progeny count of mated N2 (n = 12), drp-1 (n = 13) and fzo-1 (n = 12) after mating (L4-Day 1) and after mating confirmation (Day 1-Day 2). Day 3, 4 and 5 of adulthood were scored. 2-way ANOVA.

(PDF)

S3 Fig. Fission, not fusion, is required for daf-2 extended reproductive longevity.

(A) Representative images of young daf-2;drp-1 and daf-2.Scale bar 20μm. (B) Representative images of aged daf-2(e1370) left and daf-2(e1370);fzo-1(tm1133) germlines. Scale bar 50μm. (C) Reproductive spans of daf-2 vs. daf-2;drp-1 (Fig 3D) including N2 and drp-1 genotypes. (D) Reproductive spans of daf-2 vs. daf-2;fzo-1 (Fig 3E) including N2 and fzo-1 genotypes.

(PDF)

S4 Fig. PINK-1 mitophagy is specifically required for daf-2 reproductive span.

(A) mtRosella is silenced in the germline. Image of the dissected germline of the WMB1119 strain with Ppie-1TOMM-20::Rosella insert. Image was captured on the Nikon eclipse Ti at 60x magnification. The mCherry and FITC channels are superimposed Z-stacks taken at 0.7μm steps. (B) Mating capability of all genotypes used in this study when young hermaphrodites are mated with fog-2 males. (C) Late-mating capability in pink-1 vs. N2. Day 7 adults are mated with young males. (D) Lifespan of pink-1(tm1779) (n = 62) is unchanged compared to N2 (n = 69).

(PDF)

S5 Fig. UA treatment in aged adults.

(A) Lifespan of N2 (unmated) hermaphrodites is extended with Urolithin A treatment (n = 100) vs. 0.3% DMSO (n = 100). Worms were cultured on NGM plates seeded with OP50 during development. Treatment started with or without Urolithin A on Day 1 and loaded in the CeLab chip. (B) daf-2 reproductive span does not improve with Urolithin A treatment. DMSO control (N = 50) vs. UA treated (n = 50).

(PDF)

S1 Table. Statistical data tables.

(A) Reproductive span, (B) Late-mating, and (C) Lifespan statistical information. Statistics were performed on Prism. Mean reproductive/alive was performed on OASIS.

(DOCX)

S1 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult N2, 100x.

(AVI)

S2 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult N2, 60x.

(AVI)

S3 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult N2, 60x.

(AVI)

S4 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult daf-2(e1370), 100x.

(AVI)

S5 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult daf-2(e1370), 60x.

(AVI)

S6 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult daf-2(e1370), 60x.

(AVI)

Acknowledgments

We thank the Caenorhabditis Genetics Center (CGC) and the National BioResource Project (NBRP) for strains, Jasmine Ashraf, William Keyes, and Rebecca S. Moore for help with experiments, members of the Murphy Lab for discussion and feedback on the manuscript, Biorender.com for model figure design software. Imaging was performed with support from the Confocal Imaging Facility, a Nikon Center of Excellence, in the Department of Molecular Biology at Princeton University.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This project was funded in part by the Global Consortium for Reproductive Longevity and Equality through the Buck Institute, GCRLE-0220, to CTM. NIGMS Training grant, T32GM007388, Princeton University Molecular Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Duncan FE, Confino R, Pavone ME. Female Reproductive Aging. In: Conn’s Handbook of Models for Human Aging. Elsevier, pp. 109–130. [Google Scholar]
  • 2.Chandra A, Stephen EH. Infertility and Impaired Fecundity in the United States, 1982–2010: Data From the National Survey of Family Growth. 2013; 19. [PubMed] [Google Scholar]
  • 3.Martin JA. Births: Final Data for 2013. 68. [PubMed] [Google Scholar]
  • 4.Mills M, Rindfuss RR, McDonald P, et al. Why do people postpone parenthood? Reasons and social policy incentives. Human Reproduction Update 2011; 17: 848–860. doi: 10.1093/humupd/dmr026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Broekmans FJ, Soules MR, Fauser BC. Ovarian Aging: Mechanisms and Clinical Consequences. Endocrine Reviews 2009; 30: 465–493. doi: 10.1210/er.2009-0006 [DOI] [PubMed] [Google Scholar]
  • 6.te Velde ER. The variability of female reproductive ageing. Human Reproduction Update 2002; 8: 141–154. doi: 10.1093/humupd/8.2.141 [DOI] [PubMed] [Google Scholar]
  • 7.Hansen KR, Knowlton NS, Thyer AC, et al. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Human Reproduction 2008; 23: 699–708. doi: 10.1093/humrep/dem408 [DOI] [PubMed] [Google Scholar]
  • 8.May-Panloup P, Chretien M, Malthiery Y, et al. Mitochondrial DNA in the Oocyte and the Developing Embryo. In: Current Topics in Developmental Biology. Elsevier, pp. 51–83. [DOI] [PubMed] [Google Scholar]
  • 9.Reynier P, May-Panloup P, Chrétien M-F, et al. Mitochondrial DNA content affects the fertilizability of human oocytes. Molecular Human Reproduction 2001; 7: 425–429. doi: 10.1093/molehr/7.5.425 [DOI] [PubMed] [Google Scholar]
  • 10.Kasapoğlu I, Seli E. Mitochondrial Dysfunction and Ovarian Aging. Endocrinology; 161. Epub ahead of print 1 February 2020. doi: 10.1210/endocr/bqaa001 [DOI] [PubMed] [Google Scholar]
  • 11.Zhang D, Keilty D, Zhang ZF, et al. Mitochondria in oocyte aging: current understanding. Facts Views Vis Obgyn 2017; 9: 29–38. [PMC free article] [PubMed] [Google Scholar]
  • 12.Santel A, Fuller MT. Control of mitochondrial morphology by a human mitofusin. Journal of Cell Science 2001; 114: 867–874. doi: 10.1242/jcs.114.5.867 [DOI] [PubMed] [Google Scholar]
  • 13.Hales KG, Fuller MT. Developmentally Regulated Mitochondrial Fusion Mediated by a Conserved, Novel, Predicted GTPase. Cell 1997; 90: 121–129. [DOI] [PubMed] [Google Scholar]
  • 14.Labrousse AM, Zappaterra MD, Rube DA, et al. C. elegans Dynamin-Related Protein DRP-1 Controls Severing of the Mitochondrial Outer Membrane. Molecular Cell 1999; 4: 815–826. doi: 10.1016/s1097-2765(00)80391-3 [DOI] [PubMed] [Google Scholar]
  • 15.Smirnova E, Griparic L, Shurland D-L, et al. Dynamin-related Protein Drp1 Is Required for Mitochondrial Division in Mammalian Cells. MBoC 2001; 12: 2245–2256. doi: 10.1091/mbc.12.8.2245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Liu Q, Kang L, Wang L, et al. Mitofusin 2 regulates the oocytes development and quality by modulating meiosis and mitochondrial function. Sci Rep 2016; 6: 30561. doi: 10.1038/srep30561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhang M, Bener MB, Jiang Z, et al. Mitofusin 1 is required for female fertility and to maintain ovarian follicular reserve. Cell Death & Disease 2019; 10: 1–15. doi: 10.1038/s41419-019-1799-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Udagawa O, Ishihara T, Maeda M, et al. Mitochondrial Fission Factor Drp1 Maintains Oocyte Quality via Dynamic Rearrangement of Multiple Organelles. Current Biology 2014; 24: 2451–2458. doi: 10.1016/j.cub.2014.08.060 [DOI] [PubMed] [Google Scholar]
  • 19.Luo S, Murphy CT. Caenorhabditis elegans reproductive aging: Regulation and underlying mechanisms. Genesis 2011; 49: 53–65. doi: 10.1002/dvg.20694 [DOI] [PubMed] [Google Scholar]
  • 20.Garigan D, Hsu A-L, Fraser AG, et al. Genetic Analysis of Tissue Aging in Caenorhabditis elegans: A Role for Heat-Shock Factor and Bacterial Proliferation. 2002; 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Luo S, Kleemann GA, Ashraf JM, et al. TGF-β and Insulin Signaling Regulate Reproductive Aging via Oocyte and Germline Quality Maintenance. Cell 2010; 143: 299–312. doi: 10.1016/j.cell.2010.09.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hughes SE, Evason K, Xiong C, et al. Genetic and pharmacological factors that influence reproductive aging in nematodes. PLoS Genet 2007; doi: 10.1371/journal.pgen.0030025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Huang C, Xiong C, Kornfeld K. Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans. Proceedings of the National Academy of Sciences 2004; 101: 8084–8089. doi: 10.1073/pnas.0400848101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Luo S, Shaw WM, Ashraf J, et al. TGF-ß Sma/Mab Signaling Mutations Uncouple Reproductive Aging from Somatic Aging. PLoS Genet 2009; 5: e1000789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kenyon C, Chang J, Gensch E, et al. A C. elegans mutant that lives twice as long as wild type. Nature 1993; 366: 461–464. doi: 10.1038/366461a0 [DOI] [PubMed] [Google Scholar]
  • 26.Templeman NM, Luo S, Kaletsky R, et al. Insulin Signaling Regulates Oocyte Quality Maintenance with Age via Cathepsin B Activity. Current Biology 2018; 28: 753–760.e4. doi: 10.1016/j.cub.2018.01.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Srivastava S. The Mitochondrial Basis of Aging and Age-Related Disorders. Genes 2017; 8: 398. doi: 10.3390/genes8120398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lamarche AM dit, Molin L, Pierson L, et al. UNC-120/SRF independently controls muscle aging and lifespan in Caenorhabditis elegans. Aging Cell 2018; 17: e12713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Palikaras K, Lionaki E, Tavernarakis N. Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature 2015; 521: 525–528. doi: 10.1038/nature14300 [DOI] [PubMed] [Google Scholar]
  • 30.Regmi SG, Rolland SG, Conradt B. Age-dependent changes in mitochondrial morphology and volume are not predictors of lifespan. aging 2014; 6: 118–130. doi: 10.18632/aging.100639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wang H, Webster P, Chen L, et al. Cell-autonomous and non-autonomous roles of daf-16 in muscle function and mitochondrial capacity in aging C. elegans. Aging 2019; 11: 2295–2311. doi: 10.18632/aging.101914 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Weir HJ, Yao P, Huynh FK, et al. Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. Cell Metabolism 2017; 26: 884–896.e5. doi: 10.1016/j.cmet.2017.09.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Jiang H-C, Hsu J-M, Yen C-P, et al. Neural activity and CaMKII protect mitochondria from fragmentation in aging Caenorhabditis elegans neurons. Proc Natl Acad Sci USA 2015; 112: 8768–8773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Morsci NS, Hall DH, Driscoll M, et al. Age-Related Phasic Patterns of Mitochondrial Maintenance in Adult Caenorhabditis elegans Neurons. Journal of Neuroscience 2016; 36: 1373–1385. doi: 10.1523/JNEUROSCI.2799-15.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Chaudhari SN, Kipreos ET. Increased mitochondrial fusion allows the survival of older animals in diverse C. elegans longevity pathways. Nat Commun 2017; 8: 182. doi: 10.1038/s41467-017-00274-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Meissner B, Warner A, Wong K, et al. An Integrated Strategy to Study Muscle Development and Myofilament Structure in Caenorhabditis elegans. PLOS Genetics 2009; 5: e1000537. doi: 10.1371/journal.pgen.1000537 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Bohnert KA, Kenyon C. A lysosomal switch triggers proteostasis renewal in the immortal C. elegans germ lineage. Nature 2017; 551: 629–633. doi: 10.1038/nature24620 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hahm J-H, Kim S, DiLoreto R, et al. C. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation. Nat Commun 2015; 6: 8919. doi: 10.1038/ncomms9919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Yang CC, Chen D, Lee SS, et al. The dynamin-related protein DRP-1 and the insulin signaling pathway cooperate to modulate C. elegans longevity. Aging Cell 2011; 10: 724–728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kanazawa T, Zappaterra MD, Hasegawa A, et al. The C. elegans Opa1 Homologue EAT-3 Is Essential for Resistance to Free Radicals. PLoS Genet 2008; 4: e1000022. doi: 10.1371/journal.pgen.1000022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Twig G, Elorza A, Molina AJA, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. The EMBO Journal 2008; 27: 433–446. doi: 10.1038/sj.emboj.7601963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Lieber T, Jeedigunta SP, Palozzi JM, et al. Mitochondrial fragmentation drives selective removal of deleterious mtDNA in the germline. Nature 2019; 570: 380–384. doi: 10.1038/s41586-019-1213-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Rana A, Oliveira MP, Khamoui AV, et al. Promoting Drp1-mediated mitochondrial fission in midlife prolongs healthy lifespan of Drosophila melanogaster. Nat Commun 2017; 8: 448. doi: 10.1038/s41467-017-00525-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Silva-García CG, Lanjuin A, Heintz C, et al. Single-Copy Knock-In Loci for Defined Gene Expression in Caenorhabditis elegans. G3 Genes|Genomes|Genetics 2019; 9: 2195–2198. doi: 10.1534/g3.119.400314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Palikaras K, Tavernarakis N. In vivo Mitophagy Monitoring in Caenorhabditis elegans toDetermine Mitochondrial Homeostasis. Bio Protoc 2017; 7: e2215. doi: 10.21769/BioProtoc.2215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Fang EF, Hou Y, Palikaras K, et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nature Neuroscience 2019; 22: 401–412. doi: 10.1038/s41593-018-0332-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sämann J, Hegermann J, von Gromoff E, et al. Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth. Journal of Biological Chemistry 2009; 284: 16482–16491. doi: 10.1074/jbc.M808255200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary Early-Onset Parkinson’s Disease Caused by Mutations in PINK1. Science. Epub ahead of print 21 May 2004. doi: 10.1126/science.1096284 [DOI] [PubMed] [Google Scholar]
  • 49.Narendra DP, Jin SM, Tanaka A, et al. PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin. PLoS Biol 2010; 8: e1000298. doi: 10.1371/journal.pbio.1000298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Espín JC, Larrosa M, García-Conesa MT, et al. Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far. Evidence-Based Complementary and Alternative Medicine 2013; 2013: e270418. doi: 10.1155/2013/270418 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.González-Barrio R, Borges G, Mullen W, et al. Bioavailability of Anthocyanins and Ellagitannins Following Consumption of Raspberries by Healthy Humans and Subjects with an Ileostomy. J Agric Food Chem 2010; 58: 3933–3939. doi: 10.1021/jf100315d [DOI] [PubMed] [Google Scholar]
  • 52.Ryu D, Mouchiroud L, Andreux PA, et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nature Medicine 2016; 22: 879–888. doi: 10.1038/nm.4132 [DOI] [PubMed] [Google Scholar]
  • 53.Luan P D ’Amico D, Andreux PA, et al. Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy. Science Translational Medicine. Epub ahead of print 7 April 2021. doi: 10.1126/scitranslmed.abb0319 [DOI] [PubMed] [Google Scholar]
  • 54.Andreux PA, Blanco-Bose W, Ryu D, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab 2019; 1: 595–603. doi: 10.1038/s42255-019-0073-4 [DOI] [PubMed] [Google Scholar]
  • 55.D’Amico D, Andreux PA, Valdés P, et al. Impact of the Natural Compound Urolithin A on Health, Disease, and Aging. Trends in Molecular Medicine 2021; 27: 687–699. doi: 10.1016/j.molmed.2021.04.009 [DOI] [PubMed] [Google Scholar]
  • 56.Youle RJ, van der Bliek AM. Mitochondrial Fission, Fusion, and Stress. Science 2012; 337: 1062–1065. doi: 10.1126/science.1219855 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Bratic I, Hench J, Henriksson J, et al. Mitochondrial DNA level, but not active replicase, is essential for Caenorhabditis elegans development. Nucleic Acids Research 2009; 37: 1817–1828. doi: 10.1093/nar/gkp018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Tsang WY, Lemire BD. Mitochondrial Genome Content Is Regulated during Nematode Development. Biochemical and Biophysical Research Communications 2002; 291: 8–16. doi: 10.1006/bbrc.2002.6394 [DOI] [PubMed] [Google Scholar]
  • 59.Meléndez A, Tallóczy Z, Seaman M, et al. Autophagy Genes Are Essential for Dauer Development and Life-Span Extension in C. elegans. Science 2003; 301: 1387–1391. doi: 10.1126/science.1087782 [DOI] [PubMed] [Google Scholar]
  • 60.Singh A D ’Amico D, Andreux PA, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. CR Med; 3. Epub ahead of print 17 May 2022. doi: 10.1016/j.xcrm.2022.100633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Fonseca É, Marques CC, Pimenta J, et al. Anti-Aging Effect of Urolithin A on Bovine Oocytes In Vitro. Animals (Basel) 2021; 11: 2048. doi: 10.3390/ani11072048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974; 77: 71–94. doi: 10.1093/genetics/77.1.71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Templeman NM, Cota V, Keyes W, et al. CREB Non-autonomously Controls Reproductive Aging through Hedgehog/Patched Signaling. Developmental Cell 2020; 54: 92–105.e5. doi: 10.1016/j.devcel.2020.05.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Shaham S. Methods in cell biology. WormBook. Epub ahead of print 2006. doi: 10.1895/wormbook.1.49.1 [DOI] [Google Scholar]
  • 65.Sohrabi S, Moore RS, Murphy CT. CeAid: a smartphone application for logging and plotting Caenorhabditis elegans assays. G3 Genes|Genomes|Genetics 2021; 11: jkab259. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Gregory P Copenhaver, Arjumand Ghazi

1 Jul 2022

Dear Dr Murphy,

Thank you very much for submitting your Research Article entitled 'Oocyte mitophagy is critical for extended reproductive longevity' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some concerns about the current manuscript, especially regarding controls in several key experiments. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Arjumand Ghazi

Guest Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: In the Cota et al manuscript, the authors used the daf-2 mutant in C. elegans as a model to study the role of mitochondrial fragmentation and increased mitophagy in preserving oocyte quality towards the end of the reproductive period. Overall, the paper reported a number of interesting findings, but additional information is required to solidify the conclusions the authors put forth.

Specific comments:

1) It was previously reported that daf-2 mutants have extended reproductive span, but they also have reduced brood size. In this study, the authors performed the experiments using mated daf-2 mutants. Please include quantification of oocyte quality using unmated daf-2 as control (as in Fig 1C).

2) Are fragmented mitochondria (in oocytes) observed in other mutants with extended reproductive span, e.g., TGF beta mutants?

3) Fig 1B showed late mating capability. It’d be important for the authors to demonstrate the non-reproductive worms were mated successfully.

4) In Figure 2, the ovulation rate and total brood size of drp-1 and fzo-1 mutants need to be shown. These are important controls and would help interpret the observed reduced reproductive span phenotype. (It was previously reported that drp-1 depletion reduces brood size and increases lethality.)

5) In Figure 3D, E and FM, it’d be important to include the reproductive span and late mating capability of drp-1 and fzo-1 single mutants as controls.

6) Figure 2 showed that day-6 drp-1 and fzo-1 mutants develop severe oocyte aberration. These phenotypes should also be assessed for the daf-2 and daf-2; fzo-1 mutants in Figure 3 G, H and I.

7) For Figure 3J, the data for unhatched oocytes in daf-2;fzo-1 and single mutants, drp-1 and fzo-1, need to be included as appropriate controls.

8) In Figure 4, reproductive span data for daf-2 and daf-2;pink-1 should be included in parallel to late mating capability data in figure 4A as these two experiments have been shown together in most of the figures to measure reproductive span and oocyte quality.

9) In Figure 4, pink-1 single mutant data for oocyte quality check (uterine mass quantification), reproductive span and late mating capability need to be included as appropriate controls.

(10) The extended reproductive span of daf-2 worms depends on punctate mitochondrial morphology and mitophagy in the oocytes. In figure 4, it is shown that blocking mitophagy by depleting PINK-1 causes severe oocyte anomalies in day-8 daf-2 worms. These results suggest that pink-1 might be overexpressed or mitophagy is increased in the oocytes of daf-2 mutants. It would be important to include pink-1 expression data in daf-2 oocytes.

(11) In figure 5, the effect of Urolithin (a mitophagy promoter metabolite) on reproductive span of daf-2 mutant should be included as a control.

(12) In figure 5, it is shown that UA supplementation reduces the severity of uterine mass in fzo-1 mutants. Interestingly, drp-1 mutants also show severe uterine mass in day-6 worms (figure 2G). The authors should check the effect of UA supplementation in drp-1 mutants to specifically test whether the increased mitophagy upon excessive fragmentation (achieved by fzo-1 depletion) is the underlying mechanism for better oocyte quality in daf-2 mutants. If UA supplementation also reduces the severity of uterine mass in drp-1 mutants, then it would suggest a more general role of UA in regulating oocyte quality irrespective of the mitochondrial morphology in the oocytes.

(13) In Figure 5, the oocyte quality data upon UA supplementation in daf-2, daf-2;drp-1 and daf-2;fzo-1 on day 6 worms should be included as controls.

Minor:

In line 261, Figure 6F-G should be corrected to 5F-G.

Reviewer #2: With the first publication about daf-2 mutants living longer than wild type animals was a finding that was buried in the original paper reporting that these animals also reproduced for a longer period of time. Until the manuscript by Cota et al, the mechanism was unknown. The authors of this manuscript first find that the mitochondria found in the germline of daf-2 mutant animals are more punctate and the extended reproductive profile depends on active mitophagy. This is truly surprising because the mitochondria of the soma are elongated and trend towards fusion, rather than fission.

The authors do an excellent job of teasing apart the role for mitophagy in this process, using SKI-LODGE to assess mitophagy specifically in the germline, showing that pink1 is require for reproductive longevity, but not somatic longevity and finally, ectopic activation of mitophagy can increase the reproductive lifespan of wild type animals.

I am a huge fan of this paper and feel that no new experiments will strengthen this already strong paper. It is suggested that the authors qualify the use of Urolithin A in their studies as not solely targeting the germline since it is drug and hits all tissues.

Reviewer #3: In this very interesting manuscript, Cota et al delved into to the mechanisms of mitochondrial dynamics in regulating female reproductive longevity. Using daf-2 mutated C. elegans as a model, the authors found daf-2 mutant could extend reproductive span through shifting toward fission and activating mitophagy program to maintain oocyte quality. More importantly, they showed reproductive span could be extended by Urolithin A treatment. The present paper is original, well performed, complete, and thoughtfully interpreted. The data provide a novel approach to promote oocyte health. It would strengthen the manuscript if the authors could address the following:

Major points:

To clarify the relationship of daf-2 mutant, fission/fusion, and mitophagy, a few experiments could be conducted.

1. To support daf-2 mutant could drive a shift towards fission and activate/strengthen the mitophagy program, it would be very feasible to compare the drp-1/fzo-1 gene expression ratio and pink-1 gene expression level in oocyte from daf-2 mutant and WT C. elegans.

2. In addition to abrogating the fission/fusion, the approach that the authors used, mimicking punctate/elongated morphology would further support that fission-mediated punctate is required for mitophagy. For example, knockdown of drp-1 or overexpression of fzo-1 in daf-2 mutant C. elegans would elongate mitochondria and thus confer shorter reproductive span?

Minor concerns:

1. Please add the missing scale bar in Figure 1C, Figure 3G, and Figure 3H.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Andrew Dillin

Reviewer #3: No

Decision Letter 1

Gregory P Copenhaver, Arjumand Ghazi

29 Aug 2022

Dear Dr Murphy,

We are pleased to inform you that your manuscript entitled "Oocyte mitophagy is critical for extended reproductive longevity" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Arjumand Ghazi

Guest Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have effectively addressed the comments raised previously.

Reviewer #2: Excellent response to reviewer #1. you went far and beyond what was expected or needed to address the overwhelmingly minor comoments of reviewer 1.

Reviewer #3: The authors have made concerted efforts to constructively address my comments.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: None

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Andrew G Dillin

Reviewer #3: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-22-00628R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory P Copenhaver, Arjumand Ghazi

13 Sep 2022

PGENETICS-D-22-00628R1

Oocyte mitophagy is critical for extended reproductive longevity

Dear Dr Murphy,

We are pleased to inform you that your manuscript entitled "Oocyte mitophagy is critical for extended reproductive longevity" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Agnes Pap

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Mitochondrial morphology in N2 and daf-2 oocytes and muscle.

    (A) Day 1 adult mitochondrial morphology images in the -1 oocytes of N2 (left 2 panels) and daf-2(e1370) (right 2 panels). (B) Day 7 adult mitochondrial morphology images in the -1 oocytes of N2 (left 2 panels) and daf-2(e1370) (right 2 panels). In A and B images were taken on the Nikon eclipse Ti at 60x magnification. (C) Day 7 adult mitochondrial morphology images in the muscle of N2 (left 2 panels) and daf-2(e1370) (right 2 panels). In C images were taken on the scanning confocal Nikon A1 at 60x. All images are of mitochondria stained with ATP5α to mark membranes.

    (PDF)

    S2 Fig. Mitochondrial dynamics are specifically required for reproduction function.

    (A) Lifespans are not affected by loss of drp-1(tm1108) (n = 81, N2 n = 81) (B) fzo-1(tm1133) (n = 80, N2 n = 83). (C) Progeny count of mated N2 (n = 12), drp-1 (n = 13) and fzo-1 (n = 12) after mating (L4-Day 1) and after mating confirmation (Day 1-Day 2). Day 3, 4 and 5 of adulthood were scored. 2-way ANOVA.

    (PDF)

    S3 Fig. Fission, not fusion, is required for daf-2 extended reproductive longevity.

    (A) Representative images of young daf-2;drp-1 and daf-2.Scale bar 20μm. (B) Representative images of aged daf-2(e1370) left and daf-2(e1370);fzo-1(tm1133) germlines. Scale bar 50μm. (C) Reproductive spans of daf-2 vs. daf-2;drp-1 (Fig 3D) including N2 and drp-1 genotypes. (D) Reproductive spans of daf-2 vs. daf-2;fzo-1 (Fig 3E) including N2 and fzo-1 genotypes.

    (PDF)

    S4 Fig. PINK-1 mitophagy is specifically required for daf-2 reproductive span.

    (A) mtRosella is silenced in the germline. Image of the dissected germline of the WMB1119 strain with Ppie-1TOMM-20::Rosella insert. Image was captured on the Nikon eclipse Ti at 60x magnification. The mCherry and FITC channels are superimposed Z-stacks taken at 0.7μm steps. (B) Mating capability of all genotypes used in this study when young hermaphrodites are mated with fog-2 males. (C) Late-mating capability in pink-1 vs. N2. Day 7 adults are mated with young males. (D) Lifespan of pink-1(tm1779) (n = 62) is unchanged compared to N2 (n = 69).

    (PDF)

    S5 Fig. UA treatment in aged adults.

    (A) Lifespan of N2 (unmated) hermaphrodites is extended with Urolithin A treatment (n = 100) vs. 0.3% DMSO (n = 100). Worms were cultured on NGM plates seeded with OP50 during development. Treatment started with or without Urolithin A on Day 1 and loaded in the CeLab chip. (B) daf-2 reproductive span does not improve with Urolithin A treatment. DMSO control (N = 50) vs. UA treated (n = 50).

    (PDF)

    S1 Table. Statistical data tables.

    (A) Reproductive span, (B) Late-mating, and (C) Lifespan statistical information. Statistics were performed on Prism. Mean reproductive/alive was performed on OASIS.

    (DOCX)

    S1 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult N2, 100x.

    (AVI)

    S2 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult N2, 60x.

    (AVI)

    S3 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult N2, 60x.

    (AVI)

    S4 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult daf-2(e1370), 100x.

    (AVI)

    S5 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult daf-2(e1370), 60x.

    (AVI)

    S6 Video. Representative Z-stack of mitochondria in the -1 oocyte of Day 7 adult daf-2(e1370), 60x.

    (AVI)

    Attachment

    Submitted filename: reviewer response 080122ctm.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES